Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Neurocrine Biosciences Inc (NBIX) vs Prospect Capital Corporation (PSEC) Price & Performance

Neurocrine Biosciences IncTrade
Prospect Capital CorporationTrade

Price performance (Past 24H)

Key statistics

Neurocrine Biosciences Inc vs Prospect Capital Corporation — how do they compare? Neurocrine Biosciences Inc trades at $151.75 (market cap $16.46B), while Prospect Capital Corporation trades at $2.27 (market cap $1.14B). The key difference: Neurocrine Biosciences Inc is far larger — about 14.4× Prospect Capital Corporation's market cap, and Prospect Capital Corporation pays a 21.93% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.

NBIXPSEC
Market Cap
$16.46B$1.14B
Sector
HealthFinancials
52-Week High
$185.50$3.05
52-Week Low
$123.10$2.11
Enterprise Value
$16.48B
Dividend Yield
21.93%

Returns comparison

Trailing returns across standard periods

About Neurocrine Biosciences Inc

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.

Read more on NBIX

About Prospect Capital Corporation

Prospect Capital Corp is a closed-end investment company based in the United States. Its investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. The company invests primarily in senior and subordinated debt and equity of private companies for acquisitions, divestitures, growth, development, recapitalizations, and other purposes. It makes investments, including lending in private equity, sponsored transactions, directly to companies, investments in structured credit, real estate, and syndicated debt.

Read more on PSEC